Latest Breaking News On - Marisol peron - Page 1 : comparemela.com

Transactions with shares and linked securities in Genmab

Transactions in Connection with Share Buy-back Program

Transactions in Connection with Share Buy-back Program

Company Announcement COPENHAGEN, Denmark; May 21, 2024 – Genmab A/S (Nasdaq: GMAB). On March 15, 2024, Genmab announced the initiation of a share buy-back program to repurchase up to DKK 3.5 billion worth of shares. The share buy-back program is expected to be completed no later than December 16, 2024. The following transactions were executed under the program from May 13, 2024 to May 17, 2024: Trading PlatformNo. of sharesAverage price (DKK)Total value (DKK)Accumulated through last announcement

Genmab A/S: Genmab Completes Acquisition of ProfoundBio

Genmab has completed acquisition of ProfoundBio for USD 1.8 billion in cash Acquisition gives Genmab worldwide rights to three candidates in clinical development, including rinatabart sesutecan

Transactions in Connection with Share Buy-back Program